Search Results
Jul 29, 2026, 13:14 ET GMP Biologics Market to Reach US$98.2 Bn by 2033 Accelerates with Biopharmaceutical Innovation - Persistence Market Research
Pediatric Cancer Biomarkers Market by Product Type (Alpha-fetoprotein (AFP), Neuron-specific enolase (NSE), CD19, Others), Indication (Leukemia, Neuroblastoma, CNS Tumors, Others), End-use (Hospitals, Diagnostic Laboratories, Others), and Regional Analysis for 2026
More news about: Persistence Market Research Pvt. Ltd.
Jul 29, 2026, 09:30 ET Evinced Harnesses Agentic Coding to Automatically and Reliably Fix Accessibility Problems
new set of tools to deploy that are transformationally easy to use.AutopilotAutopilot is an Evinced capability that runs inside CI/CD systems and alongside a customer's LLM. It detects accessibility defects, with the industry's most powerful detection, when code is submitted into the CI
More news about: Evinced
Jul 29, 2026, 08:59 ET Marshmellow Overcoat Channels Classic Rock Spirit on New Album 'Beat a Dead Horse'
donate half of its album and merchandise sales from the day.With 'Beat a Dead Horse' now available on all digital platforms, as well as vinyl and CD, Marshmellow Overcoat continues to deliver on its promise of classic rock and roll for today.Media Contact: Eric Alper Public Relations647-971-3742
More news about: Marshmellow Overcoat
Jul 29, 2026, 07:00 ET BANKFIRST CAPITAL CORPORATION Reports Second Quarter 2026 Earnings of $8.66 Million
Alabama. BankFirst offers a wide variety of services for businesses and consumers. The Bank also offers internet banking, no-fee ATM access, checking, CD, and money market accounts, merchant services, mortgage loans, remote deposit capture, and more. For more information, visit
More news about: BankFirst Capital Corporation
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
exposure, skin papilloma was reported in adolescents in the RINVOQ 15 mg and 30 mg groups.The most commonly reported adverse reactions in the UC and CD trials (≥3% of patients) with RINVOQ 45 mg, 30 mg or 15 mg were upper respiratory tract infection, pyrexia, blood CPK increased, anemia, headache, acne,
More news about: AbbVie
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
exposure, skin papilloma was reported in adolescents in the RINVOQ 15 mg and 30 mg groups.The most commonly reported adverse reactions in the UC and CD trials (≥3% of patients) with RINVOQ 45 mg, 30 mg or 15 mg were upper respiratory tract infection, pyrexia, blood CPK increased, anemia, headache, acne,
More news about: AbbVie
Jul 28, 2026, 20:30 ET Subaru Wins CNCF End User Case Study Contest for Accelerating AI Development with Cloud Native Infrastructure
hours to three minutes, a 60x improvement, by optimizing its Kubernetes networking architecture using Envoy Gateway.By adopting GitOps with Argo CD and Helmfile, Subaru standardized application deployments and improved reproducibility across its AI development environments.Using Argo Workflows,
More news about: Cloud Native Computing Foundation
Jul 28, 2026, 12:00 ET CNCF Announces Schedule for Debut Observability Summit Europe
OpenTelemetry Beyond Observability: Security, CI/CD, and Network Management - Antoine Toulme, CiscoView the full CNCF Observability Projects track
More news about: Cloud Native Computing Foundation
Jul 28, 2026, 08:08 ET CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics
Platform Co., Ltd. and Elikon Venture, alongside participation from InnoPinnacle Fund, Mitsubishi UFJ Capital Co., Ltd., Suzhou Capital Group Co., Ltd., CD Capital, YuanBio Venture Capital, Vision Incubate Co., Ltd., and Root Venture Partners. CORE's lineage-based approach is designed to identify and target
More news about: CORE Biomedicine
Jul 28, 2026, 07:00 ET ECARX to Report Second Quarter 2026 Financial Results on August 11, 2026
https://register-conf.media-server.com/register/BIe8abcb76ec1e4761a1002346ff30cd05 to receive the conference call details as well as international access numbers.Please join at least
More news about: ECARX Holdings Inc.
Jul 28, 2026, 07:00 ET Act Security Launches Action-Centric Cloud Security Platform With $60 Million in Funding
prevent access erosion over time, ensuring new sprawl is not created. The platform continuously validates and tightens boundaries and extends into the CI/CD pipeline so new access violations never reach production.Achieve provable, continuous compliance with perimeter and data-boundary enforcement
More news about: Act Security
Jul 28, 2026, 07:00 ET Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
2773-2169, https://doi.org/10.1016/j.pscia.2026.100125.8 Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML. Recent Progress in the Development of Opaganib for the Treatment of Covid-19. Drug
More news about: RedHill Biopharma Ltd.
Jul 27, 2026, 12:42 ET CD Valet Leverages Trustpilot to Bring Authentic Customer Reviews to Nation's Largest CD Marketplace
feedback.About CD Valet CD Valet is a CD marketplace that features verified CD rates from federally insured banks and credit unions. With tens of thousands of CD offers tracked across the country, CD Valet gives savers a clear view of top rates and helps them explore high-yield CD options with
More news about: CD Valet
Jul 27, 2026, 09:05 ET AbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis
Regenerative Medicine Advanced Therapy (RMAT) designation regarding the multiple-center registrational Phase II clinical trial for C-CAR168, an anti-CD20/BCMA bispecific CAR-T, in the treatment of patients with Lupus Nephritis (LN) refractory to standard therapy. The Phase II trial will further evaluate
More news about: AbelZeta Pharma, Inc.
Jul 23, 2026, 16:29 ET Charter Announces Debt Exchange Offers
$1,250,000,000161175CD4 / US161175CD447
More news about: Charter Communications, Inc.
Jul 23, 2026, 14:30 ET MSI Launches 6th Gen AMD EPYC™ Server Portfolio
deployments.CD281-S4091-X2: 2OU 2-Node (1P SP7, air-cooled)CD181-S4091-X2: 1OU 2-Node (1P SP7, liquid-cooled)CD282-S6091-X2: 2OU 2-Node (2P SP7, air-cooled)CD182-S6091-X2: 1OU 2-Node (2P SP7, liquid-cooled)CD281-S4081-X2: 2OU 2-Node (1P SP8, air-cooled)Enterprise
More news about: MSI
Jul 23, 2026, 08:47 ET Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid Tumors
hematologic malignancies. BAT8013 was developed using Bio-Thera's anti-CD25 antibody and Bio-Thera's proprietary ADC linker-payload combination that includes a systemically stable and cleavable linker and a small molecule topoisomerase I inhibitor. CD25 is differentially overexpressed on Tregs in the solid tumor
More news about: Bio-Thera Solutions, Ltd
Jul 23, 2026, 08:30 ET TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma
TALVEY® + pomalidomide in adult patients with relapsed or refractory multiple myeloma (RRMM) who received 1 to 4 prior lines of therapy, including an anti-CD38 antibody and lenalidomide.1 The study demonstrated statistically significant and clinically meaningful improvements in progression-free
More news about: Johnson & Johnson
Jul 23, 2026, 08:03 ET SafeLogic Unveils SafeLogic CPM: A Comprehensive Cryptographic Posture Management Solution for the Transition to Post-Quantum Cryptography
snapshots, SafeLogic CPM continuously discovers cryptography across the software lifecycle. The solution combines multiple discovery methods including CI/CD pipeline scanning, host-based analysis, network TLS discovery, and runtime telemetry to build a single correlated inventory of cryptographic assets.Evgeny
More news about: SafeLogic
Jul 23, 2026, 02:08 ET Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
of hematopoietic stem cells. Acquired PIGA mutations in hematopoietic stem cells cause deficiencies in complement-regulatory proteins, including CD55 and CD59, and constitute the principal molecular basis of complement-mediated intravascular hemolysis in PNH. PNH is primarily characterized by intravascular
More news about: Haisco Pharmaceutical Group Co., Ltd.
Jul 22, 2026, 14:09 ET Radnor Property Group and Madrone Community Development Foundation Reach Financial Close on $147MM Combined Student Housing Development in Atlanta
and be ready for occupancy by Fall 2028.The development team includes Radnor Property Group as lead development partner, Clark Construction and CD Moody Construction in a joint venture as construction manager, Moody Nolan as architect, and Pape-Dawson as civil engineer."It is a privilege
More news about: Radnor Property Group
Jul 22, 2026, 11:01 ET Sony FX5 5K Cinema Camera Announced - First Look YouTube Video at B&H Photo Video
a tilting removable 3.68M OLED EVF with wide color gamut compatibility and a peak brightness of 2500 cd/m², as well as a USB-C to BNC Timecode cable.Learn More about the
More news about: B&H Photo
Jul 22, 2026, 11:00 ET Eurofins Viracor Launches BKV inSIGHT™ T-Cell Immunity Panel to Support BK Virus Immune Monitoring in Kidney Transplant Patients
2Azhar A, Abebe G, Biswas C, Flebbe-Rehwoldt L, Saeed M, Athreya A, Moinuddin I, Gupta G, Kleiboeker S. Antigen-Specific CD4+ T Cell Immunity Predicts Control of BK Viremia. Abstract 1091. Presented at the American Transplant Congress (ATC) 2026; June 23, 2026.About
More news about: Viracor Eurofins
Jul 22, 2026, 11:00 ET Harness Launches AppSec Alliance to Unite Best-of-Breed Partners for End-to-End Application, API & Agent Security
Shift left with SAST & SCA. AI-powered static analysis with reachability analysis, prompt and skill scanning, built natively into the CI/CD pipeline, cutting false positives through deduplication and intelligent prioritization.Software and AI Supply Chain Security. SBOM and
More news about: Harness
Jul 22, 2026, 11:00 ET Kata Containers 4.0 Cements the Project's Role as the Open Source Standard for Sandboxing AI Agents
of lightweight virtual machines. The project is managed by the OpenInfra Foundation and is used across multi-tenant Kubernetes environments, secure CI/CD pipelines and, increasingly, AI infrastructure.***
More news about: OpenInfra Foundation